Key facts
- Agile Devices’s last known valuation is $12.5M (Dec 2024).
- It has raised $5.0M across 5 recorded rounds; the latest was Seed Round ($940K) in Dec 2024.
- Notable investors include Bantam Group, Launchpad Venture Group, Symbiotic Ventures, Angel Star Ventures, Beacon Venture Partners — 19 tracked in total.
- Agile Devices has filed 7 Form Ds with the SEC since 2015, most recently Dec 2024 ($940K sold to 57 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Agile Devices
Funding rounds
5 roundsAbout Agile Devices
Developer of steerable and deflectable microcatheters designed to enhance the precision of interventional radiology procedures. The company's platform offers active tip control to adjust the catheter tip angle during operations and ultimately aims to improve patient outcomes in complex vascular cases, enabling clinicians to reduce procedure time and cost and minimize the need for device exchanges.
- Sector
- Healthcare
- HQ
- Newton, MA, United States
- Founded
- 2013
- Employees
- 8
- Website
- agiledevices.com/
- Ownership
- Privately Held (backing)
Agile Devices doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Agile Devices shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Agile Devices in its N-PORT filings yet. We sweep new filings monthly.